Application

15205372 · 4-(8-METHOXY-1-((1-METHOXYPROPAN-2-YL)-2-(TETRAHYDRO-2H-PYRAN-4-YL)-1 H-IMIDAZO[4,5-C]QUINOLIN-7-YL)-3,5-DIMETHYLISOXAZOLE AND ITS USE AS BROMODOMAIN INHIBITOR

Filed 2016-07-08 · Granted · Patent 9610284 (2017-04-04) The official file ↗The patent and its PDF ↗ · Art unit 1625 · Examiner Heidi L Reese Easy · CPC A61K 31/4745 · GlaxoSmithKline LLC · GlaxoSmithKline

Office actions

first was Notice of allowance

RCEs

no appeal

To first action

4.3 mo

to disposition 8.9 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.